Showing results 1 to 4 of 4
| Title | Author(s) | Issue Date | |
|---|---|---|---|
CDK4/6 inhibitor plus endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: The new standard of care Journal:Asia-Pacific Journal of Clinical Oncology | 2021 | ||
Emerging data and future directions for CDK4/6 inhibitor treatment of patients with hormone receptor positive HER2-non-amplified metastatic breast cancer Journal:Asia-Pacific Journal of Clinical Oncology | 2018 | ||
Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm Journal:Asia-Pacific Journal of Clinical Oncology | 2018 | ||
Optimizing care for younger women with hormone receptor-positive, HER2-negative metastatic breast cancer Journal:Asia-Pacific Journal of Clinical Oncology | 2020 |